Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin

Biochemical and Biophysical Research Communications

Volumn 410, Issue 1, 2011, Pages 114-120

  Yang, Hui ^a   Zhou, Xiaoping ^b   Liu, Xiaoyu ^a   Yang, Ling ^a   Chen, Qiang ^b   Zhao, Dongliang ^b   Zuo, Ji ^a   Liu, Wen ^a  

^a FUDAN UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Mitochondrial dysfunction; Mortalin; Oxidative damage; Parkin; Parkinson's disease

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHAPERONE; HYDROGEN PEROXIDE; MORTALIN; PARKIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LENTIVIRINAE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; WILD TYPE;

APOPTOSIS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HELA CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN TRANSPORT; UBIQUITIN-PROTEIN LIGASES;

LENTIVIRUS;

EID: 79959374989     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.116     Document Type: Article

References (20)

1. Geisler S., Holmström K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12:119-131.
2. Rothfuss O., Fischer H., Hasegawa T., Maisel M., Leitner P., Miesel F., Sharma M., Bornemann A., Berg D., Gasser T., Patenge N. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair. Hum. Mol. Genet. 2009, 18:3832-3850.
3. Grunewald A., Voges L., Rakovic A., Kasten M., Vandebona H., Hemmelmann C., Lohmann K., Orolicki S., Ramirez A., Schapira A.H., Pramstaller P.P., Sue C.M., Klein C. Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts. PLoS ONE 2010, 5:e12962.
4. Poole A.C., Thomas R.E., Andrews L.A., McBride H.M., Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. USA 2008, 105:1638.
5. Wadhwa R., Taira K., Kaul S.C. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?. Cell Stress Chaperones 2002, 7:309-316.
6. Liu Y., Liu W., Song X.D., Zuo J. Effect of GRP75/mthsp70/PBP74/mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells. Mol. Cell. Biochem. 2005, 268:45-51.
7. Burbulla L.F., Schelling C., Kato H., Rapaport D., Woitalla D., Schiesling C., Schulte C., Sharma M., Illig T., Bauer P., Jung S., Nordheim A., Schols L., Riess O., Kruger R. Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis. Hum. Mol. Genet. 2010, 19:4437-4452.
8. Jin J., Hulette C., Wang Y., Zhang T., Pan C., Wadhwa R., Zhang J. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol. Cell Proteomics 2006, 5:1193-1204.
9. Ehrhardt C., Schmolke M., Matzke A., Knoblauch A., Will C., Wixler V., Ludwig S. Polyethylenimine, a cost-effective transfection reagent. Signal Transduction 2006, 6:179-184.
10. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., Carpenter A.E., Foo S.Y., Stewart S.A., Stockwell B.R., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M., Root D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
11. Taanman J.W., Daras M., Albrecht J., Davie C.A., Mallam E.A., Muddle J.R., Weatherall M., Warner T.T., Schapira A.H.V., Ginsberg L. Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Neuromuscul. Disord. 2009, 19:151-154.
12. Wieckowski M., Giorgi C., Lebiedzinska M., Duszynski J., Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 2009, 4:1582-1590.
13. Koopman W.J., Visch H.J., Verkaart S., van den Heuvel L.W., Smeitink J.A., Willems P.H. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am. J. Physiol. Cell Physiol. 2005, 289:C881-C890.
14. Pendergrass W., Wolf N., Poot M. Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Cytometry A 2004, 61:162-169.
15. Clay Montier L.L., Deng J.J., Bai Y. Number matters: control of mammalian mitochondrial DNA copy number. J. Genet. Genomics 2009, 36:125-131.
16. Greene J.C., Whitworth A.J., Andrews L.A., Parker T.J., Pallanck L.J. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum. Mol. Genet. 2005, 14:799-811.
17. Palacino J.J., Sagi D., Goldberg M.S., Krauss S., Motz C., Wacker M., Klose J., Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 2004, 279:18614-18622.
18. Muftuoglu M., Elibol B., Dalmizrak O., Ercan A., Kulaksiz G., Ogus H., Dalkara T., Ozer N. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord. 2004, 19:544-548.
19. Rakovic A., Grünewald A., Seibler P., Ramirez A., Kock N., Orolicki S., Lohmann K., Klein C. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients. Hum. Mol. Genet. 2010, 19:3124-3137.
20. Zhu J., Chu C.T. Mitochondrial dysfunction in Parkinson's disease. J. Alzheimers Dis. 2010, 20(Suppl. 2):S325-S334.